Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Insights and Forecast to 2028

Report ID: 1803384 | Published Date: Feb 2026 | No. of Page: 91 | Base Year: 2025 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Blood Transfusion
        1.2.3 Antibiotic
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Perspective (2017-2028)
    2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Growth Trends by Region
        2.2.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Region (2017-2022)
        2.2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Region (2023-2028)
    2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Dynamics
        2.3.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Industry Trends
        2.3.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers
        2.3.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges
        2.3.4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue
        3.1.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue (2017-2022)
        3.1.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Players (2017-2022)
    3.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue
    3.4 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio
        3.4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue in 2021
    3.5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Key Players Head office and Area Served
    3.6 Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Solution and Service
    3.7 Date of Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Type
    4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Type (2017-2022)
    4.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Type (2023-2028)
5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Application
    5.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Application (2017-2022)
    5.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
    6.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
        6.2.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
        6.2.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
        6.2.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
    6.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
        6.3.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
        6.3.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
        6.3.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
    6.4 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
        6.4.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
        6.4.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
    7.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
        7.2.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
        7.2.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
        7.2.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
    7.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
        7.3.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
        7.3.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
        7.3.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
    7.4 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
        7.4.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
        7.4.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
    8.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
        8.2.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
        8.3.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
    8.4 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region
        8.4.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
    9.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
        9.2.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
        9.2.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
        9.2.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
    9.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
        9.3.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
        9.3.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
        9.3.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
    9.4 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
        9.4.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
        9.4.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028)
    10.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
        10.2.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
        10.3.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028)
    10.4 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
        10.4.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Aeolus Pharmaceuticals, Inc.
        11.1.1 Aeolus Pharmaceuticals, Inc. Company Details
        11.1.2 Aeolus Pharmaceuticals, Inc. Business Overview
        11.1.3 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
        11.1.4 Aeolus Pharmaceuticals, Inc. Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
        11.1.5 Aeolus Pharmaceuticals, Inc. Recent Developments
    11.2 Atox Bio Ltd
        11.2.1 Atox Bio Ltd Company Details
        11.2.2 Atox Bio Ltd Business Overview
        11.2.3 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
        11.2.4 Atox Bio Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
        11.2.5 Atox Bio Ltd Recent Developments
    11.3 BCN Biosciences LLC
        11.3.1 BCN Biosciences LLC Company Details
        11.3.2 BCN Biosciences LLC Business Overview
        11.3.3 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
        11.3.4 BCN Biosciences LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
        11.3.5 BCN Biosciences LLC Recent Developments
    11.4 Cellphire Inc
        11.4.1 Cellphire Inc Company Details
        11.4.2 Cellphire Inc Business Overview
        11.4.3 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
        11.4.4 Cellphire Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
        11.4.5 Cellphire Inc Recent Developments
    11.5 Daiichi Sankyo Co Ltd
        11.5.1 Daiichi Sankyo Co Ltd Company Details
        11.5.2 Daiichi Sankyo Co Ltd Business Overview
        11.5.3 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
        11.5.4 Daiichi Sankyo Co Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
        11.5.5 Daiichi Sankyo Co Ltd Recent Developments
    11.6 FirstString Research Inc
        11.6.1 FirstString Research Inc Company Details
        11.6.2 FirstString Research Inc Business Overview
        11.6.3 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
        11.6.4 FirstString Research Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
        11.6.5 FirstString Research Inc Recent Developments
    11.7 RxBio Inc
        11.7.1 RxBio Inc Company Details
        11.7.2 RxBio Inc Business Overview
        11.7.3 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
        11.7.4 RxBio Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
        11.7.5 RxBio Inc Recent Developments
    11.8 Shuttle Pharmaceuticals LLC
        11.8.1 Shuttle Pharmaceuticals LLC Company Details
        11.8.2 Shuttle Pharmaceuticals LLC Business Overview
        11.8.3 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
        11.8.4 Shuttle Pharmaceuticals LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
        11.8.5 Shuttle Pharmaceuticals LLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Blood Transfusion
    Table 3. Key Players of Antibiotic
    Table 4. Key Players of Others
    Table 5. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Region (2017-2022)
    Table 9. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Region (2023-2028)
    Table 11. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Trends
    Table 12. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers
    Table 13. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges
    Table 14. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
    Table 15. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Share by Players (2017-2022)
    Table 17. Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) as of 2021)
    Table 18. Ranking of Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Solution and Service
    Table 22. Date of Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Type (2017-2022)
    Table 26. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Type (2023-2028)
    Table 28. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Share by Application (2017-2022)
    Table 30. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Share by Application (2023-2028)
    Table 32. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Aeolus Pharmaceuticals, Inc. Company Details
    Table 63. Aeolus Pharmaceuticals, Inc. Business Overview
    Table 64. Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
    Table 65. Aeolus Pharmaceuticals, Inc. Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) & (US$ Million)
    Table 66. Aeolus Pharmaceuticals, Inc. Recent Developments
    Table 67. Atox Bio Ltd Company Details
    Table 68. Atox Bio Ltd Business Overview
    Table 69. Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
    Table 70. Atox Bio Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) & (US$ Million)
    Table 71. Atox Bio Ltd Recent Developments
    Table 72. BCN Biosciences LLC Company Details
    Table 73. BCN Biosciences LLC Business Overview
    Table 74. BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
    Table 75. BCN Biosciences LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) & (US$ Million)
    Table 76. BCN Biosciences LLC Recent Developments
    Table 77. Cellphire Inc Company Details
    Table 78. Cellphire Inc Business Overview
    Table 79. Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
    Table 80. Cellphire Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) & (US$ Million)
    Table 81. Cellphire Inc Recent Developments
    Table 82. Daiichi Sankyo Co Ltd Company Details
    Table 83. Daiichi Sankyo Co Ltd Business Overview
    Table 84. Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
    Table 85. Daiichi Sankyo Co Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) & (US$ Million)
    Table 86. Daiichi Sankyo Co Ltd Recent Developments
    Table 87. FirstString Research Inc Company Details
    Table 88. FirstString Research Inc Business Overview
    Table 89. FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
    Table 90. FirstString Research Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) & (US$ Million)
    Table 91. FirstString Research Inc Recent Developments
    Table 92. RxBio Inc Company Details
    Table 93. RxBio Inc Business Overview
    Table 94. RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
    Table 95. RxBio Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) & (US$ Million)
    Table 96. RxBio Inc Recent Developments
    Table 97. Shuttle Pharmaceuticals LLC Company Details
    Table 98. Shuttle Pharmaceuticals LLC Business Overview
    Table 99. Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
    Table 100. Shuttle Pharmaceuticals LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) & (US$ Million)
    Table 101. Shuttle Pharmaceuticals LLC Recent Developments
    Table 102. Research Programs/Design for This Report
    Table 103. Key Data Information from Secondary Sources
    Table 104. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type: 2021 VS 2028
    Figure 2. Blood Transfusion Features
    Figure 3. Antibiotic Features
    Figure 4. Others Features
    Figure 5. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Report Years Considered
    Figure 9. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Region: 2021 VS 2028
    Figure 12. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Players in 2021
    Figure 13. Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue in 2021
    Figure 15. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Type (2017-2028)
    Figure 17. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Application (2017-2028)
    Figure 18. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Share by Country (2017-2028)
    Figure 19. United States Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Share by Country (2017-2028)
    Figure 25. Germany Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Share by Region (2017-2028)
    Figure 35. China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Share by Country (2017-2028)
    Figure 45. Mexico Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Share by Country (2017-2028)
    Figure 51. Turkey Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. South Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (2017-2028) & (US$ Million)
    Figure 55. Aeolus Pharmaceuticals, Inc. Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
    Figure 56. Atox Bio Ltd Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
    Figure 57. BCN Biosciences LLC Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
    Figure 58. Cellphire Inc Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
    Figure 59. Daiichi Sankyo Co Ltd Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
    Figure 60. FirstString Research Inc Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
    Figure 61. RxBio Inc Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
    Figure 62. Shuttle Pharmaceuticals LLC Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aeolus Pharmaceuticals, Inc.
Atox Bio Ltd
BCN Biosciences LLC
Cellphire Inc
Daiichi Sankyo Co Ltd
FirstString Research Inc
RxBio Inc
Shuttle Pharmaceuticals LLC
Frequently Asked Questions
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cow Mat

Cow Mat market is segmented by Type and by Application. Players, stakeholders, and other particip ... Read More

Allen Key

Allen Key market is segmented by Type and by Application. Players, stakeholders, and other partic ... Read More